Zobrazeno 1 - 10
of 458
pro vyhledávání: '"lcnec"'
Autor:
Taghreed I. Alshafeiy, Hazwa Karathanathodi Hamza, Reem Al-Mazroui, Badriya Al-Qassabi, Suad Al-Aghbari
Publikováno v:
The Egyptian Journal of Radiology and Nuclear Medicine, Vol 55, Iss 1, Pp 1-6 (2024)
Abstract Background Primary breast carcinoma is far more common than breast metastases. Common breast metastases usually come from lymphoma, leukemia, melanoma, and ovarian cancers. Breast metastases from neuroendocrine carcinomas are considered an e
Externí odkaz:
https://doaj.org/article/1016fc01205f4da1a358e7e8a5fbca59
Publikováno v:
Human Vaccines & Immunotherapeutics, Vol 20, Iss 1 (2024)
ABSTRACTImmune checkpoint inhibitors (ICIs) have emerged as a promising therapeutic option for large cell neuroendocrine carcinoma (LCNEC). However, various studies have suggested a potential risk of hyperprogressive disease (HPD) in patients receivi
Externí odkaz:
https://doaj.org/article/4bdbddadbc0142e580911cf85e32913c
Publikováno v:
Research and Reports in Urology, Vol Volume 16, Pp 137-142 (2024)
Pan Gao,1,* Xinyu Li,1,* Ziqiu He,1 Yifan Xu,2 Zhi Zhang1 1Department of Urology, Second People’s Hospital of Yichang, Second People’s Hospital of China Three Gorges University, Yichang, Hubei Province, People’s Republic of China; 2Depa
Externí odkaz:
https://doaj.org/article/cb1cc7726b75465cb3e178b19efa2dc4
Publikováno v:
Frontiers in Oncology, Vol 14 (2024)
Combined large cell neuroendocrine carcinoma (CLCNEC) is a rare neuroendocrine carcinoma, accounting for approximately 10% of large cell neuroendocrine carcinoma (LCNEC). Mainly composed of coexisting adenocarcinoma components, with strong invasivene
Externí odkaz:
https://doaj.org/article/52c72d394cc14737bb315068dab193d0
Publikováno v:
Frontiers in Oncology, Vol 14 (2024)
ObjectiveTo improve the understanding, diagnosis and treatment of bladder large cell neuroendocrine carcinoma (LCNEC).MethodsA clinical case of bladder LCNEC admitted to our hospital was reported. The epidemiology, prognosis, diagnosis and treatment
Externí odkaz:
https://doaj.org/article/f462cef2144243b2ba6c5b2bdafeedad
Primary large-cell neuroendocrine carcinoma on the back of left shoulder: A rare case in a rare site
Publikováno v:
Asian Journal of Surgery, Vol 47, Iss 5, Pp 2322-2323 (2024)
Externí odkaz:
https://doaj.org/article/d78fc5f0bcff475389e0b43361e5495c
Publikováno v:
Journal of Cardiothoracic Surgery, Vol 18, Iss 1, Pp 1-7 (2023)
Abstract Background Combined large cell neuroendocrine carcinoma (C-LCNEC) has a poor prognosis and there is no consensus about the treatment regimen for both LCNEC and C-LCNEC patients. Case presentation The patient was a 47-year-old female who rece
Externí odkaz:
https://doaj.org/article/37ff4ff5d707407ea870a85222050b00
Autor:
Georgios Evangelou, Ioannis P. Trontzas, Ioannis Gkiozos, Ioannis Vamvakaris, Christina Paraskeva, Maria Grammoustianou, Georgia Gomatou, Ioannis Tsamis, Ioannis Vathiotis, Maximillian Anagnostakis, Vasiliki Koliaraki, Kostas Syrigos
Publikováno v:
Biomedicines, Vol 12, Iss 6, p 1161 (2024)
Background: Large cell neuroendocrine carcinoma (LCNEC) presents significant treatment challenges due to its rarity and limited therapeutic options. The LANCE study was designed to explore the survival benefits of incorporating atezolizumab in chemot
Externí odkaz:
https://doaj.org/article/a64e205bb14249d682421540974daf80
Autor:
Ryosuke Imai, Atsushi Kitamura
Publikováno v:
Respirology Case Reports, Vol 11, Iss 8, Pp n/a-n/a (2023)
Abstract In this report, a modified regimen based on IMpower 133 (carboplatin + etoposide + atezolizumab) was administered to a patient diagnosed with large cell neuroendocrine carcinoma (LCNEC) who was concurrently undergoing haemodialysis. Adverse
Externí odkaz:
https://doaj.org/article/a412106a9f8747439d8d1b6337c479d5
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.